Abstract
Leishmaniases are neglected diseases caused by parasites of the genus Leishmania, for which there is no suitable treatment or control. Available therapies are expensive, presenting high toxicity levels, and can induce drug resistance in the parasites. All of these issues highlight the need to seek new therapeutic targets and to understand the parasite life cycle and the biological issues …